1 / 52
Featured in this issue:
Volume 13 Number 2
CARVEDILOL:
- is indicated
twice daily
for
mild to moderate stable
symptomatic congestive heart
failure
- is indicated
once daily
for
essential mild to moderate
hypertension
-
has a positive effect
on
metabolic parameters.
1
RESTORE
cardiac function
CUSTOMER CARE LINE
0860 PHARMA (742 762)
www.pharmadynamics.co.zaA Lupin Group Company
Carvetrend 6,25 mg.
Each tablet contains 6,25 mg carvedilol. Reg. No.: RSA S3 A37/7.1.3/0276. NAM NS2 08/7.1.3/0105. BOT S2 BOT1101790.
Carvetrend 12,5 mg.
Each tablet contains 12,5 mg carvedilol. Reg. No.: RSA S3 A37/7.1.3/0277. NAM NS2 08/7.1.3/0104. BOT S2 BOT1101791.
Carvetrend 25 mg.
Each tablet contains 25 mg carvedilol. Reg. No.: RSA S3 A37/7.1.3/0278. NAM NS2 08/7.1.3/0103. BOT S2 BOT1101792. For full
prescribing information, refer to the package insert approved by the Medicines Control Council, 16 September 2004.
1)
Panagiotis C Stafylas, Pantelis
A Sarafidis. Carvedilol in hypertension treatment. Vascular Health and Risk Management 2008;4(1):23-30.
CDD199/04/2016.
C A R V E D I L O L
6,25 mg 12,5 mg 25 mg
CDD199/04/2016_SAJDVDffc_8Nov2016.indd 1
2016/11/08 9:19 AM
December 2016
SAJDVD
The South African Journal of Diabetes & Vascular Disease
Reviews
Ethics Focus
Achieving Best Practice Diabetes Educator’s Focus
News
The electronic version of
the journal is available at
www.diabetesjournal.co.zaType 2 diabetes and
chronic kidney disease:
echocardiographic study
Effects of
Prosopis
glandulosa
in rat models of
pre-diabetes
SES versus BMS in coronary
artery disease patients with
diabetes
Topical rifamycin in on-pump
coronary artery bypass graft
surgery
Mean platelet volume
associated with myocardial
perfusion defect
Changing perspectives on
adipose tissue
Epidemiology of ischaemic
heart disease in sub-
Saharan Africa
Guidelines on transcatheter
aortic valve implantation in
South Africa